Document Detail

Combination medical therapy for symptomatic benign prostatic hyperplasia.
MedLine Citation:
PMID:  11305957     Owner:  NLM     Status:  Publisher    
PURPOSE: The purpose of this study was to evaluate treatment response to terazosin, finasteride, or a combination of both in men with symptomatic benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: Patients with BPH were consecutively enrolled from a clinical urology practice. International Prostate Symptom Score (IPSS), peak urinary flow rate, and prostate volume were assessed at baseline and every 2 months for 12 months. Detrusor pressure at maximum flow was assessed at baseline, 4 and 12 months. Patients were randomized into 1 of 3 treatment groups - terazosin alone, finasteride alone, or combination therapy. RESULTS: At 12 months, symptom scores had decreased significantly in all 3 treatment groups (p<0.05). Combination therapy resulted in significantly greater reductions in IPSS than terazosin or finasteride (6.4, 4.9, 4.1 points, respectively, p<0.05) There were significant increases in peak urinary flow rate within each treatment group, although there were no significant changes between groups. Detrusor pressure also significantly decreased from baseline within each treatment group. Patients treated with combination therapy had a significantly greater mean decrease in detrusor pressure after 12 months when compared with finasteride-treated patients (16.7 versus 10.5 cm H20, p<0.03). There were no significant differences between terazosin and combination therapy or between terazosin and finasteride despite the relatively greater decrease in detrusor pressure seen in the terazosin group when compared with the finasteride group. CONCLUSIONS: Combination medical therapy with finasteride and terazosin provides greater symptom relief than monotherapy in men with BPH.
Stephen J. Savage; Ann M. Spungen; Giuseppe Galea; Josephine Britanico; Jonathan M. Vapnek
Related Documents :
8465017 - Time trend of patient setup deviations during pelvic irradiation using electronic porta...
7689387 - Transurethral microwave thermotherapy for benign prostatic hyperplasia: a 2-year follow...
11108567 - Transurethral microwave thermotherapy of the prostate without intravenous sedation: res...
16600727 - Intermittent use of testosterone inactivating pharmaceuticals using finasteride prolong...
9546507 - Effects of resective surgery for left-sided intracranial tumours on language function: ...
6424827 - Optimal timing of operation for bleeding peptic ulcer: prospective randomised trial.
Publication Detail:
Journal Detail:
Title:  The Canadian journal of urology     Volume:  5     ISSN:  1195-9479     ISO Abbreviation:  Can J Urol     Publication Date:  1998 Aug 
Date Detail:
Created Date:  2001-Apr-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9515842     Medline TA:  Can J Urol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  578-584     Citation Subset:  -    
Department of Urology, The Mount Sinai School of Medicine, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Low frequency of E-cadherin alterations in familial breast cancer.
Next Document:  Meta-analysis and economic evaluation of LH-RH agonists' depot formulations in advanced prostatic ca...